Drug recall
Pathogen Reduced Cryoprecipitated Fibrinogen Complex
FDA recall event 99464 · Class II · Stanford Blood Center LLC
Key facts
| Event ID | 99464 |
|---|---|
| Recall numbers | B-0194-2026, B-0195-2026 |
| Recalling firm | Stanford Blood Center LLC |
| Product type | Biologics |
| Products | Pathogen Reduced Cryoprecipitated Fibrinogen Complex, Red Blood Cells, Leukocytes Reduced |
| Classification | Class II |
| Status | Terminated |
| Voluntary or mandated | Voluntary: Firm Initiated |
| Reason for recall | Pathogen Reduced Cryoprecipitated Fibrinogen Complex, collected in a manner with a potential for air contamination, was distributed., Red Blood Cells, Leukocytes Reduced, collected in a manner with a potential for air contamination, were distributed. |
| Initiation date | Mar 2, 2026 |
| Report date | Sep 16, 2026 |
| Termination date | Sep 4, 2026 |
| City | Campbell |
| State | CA |
| Country | United States |
| FEI number | 3014947504 |
At a glance
- 1–9 Products in this recall
- None FDA inspections of this firm (FEI)
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About FDA drug and product recalls
FDA enforcement reports list recalls of drugs, biologics, foods and other FDA-regulated products, classified by the potential health hazard.
Source: U.S. Food and Drug Administration (FDA), Enforcement Reports · Source date: